Cardiac Fas Receptor‐dependent Apoptotic Pathway in Obese Zucker Rats
Objective: Very limited information regarding the cardiac molecular mechanism in obesity is available. The purpose of this study was to evaluate the cardiac Fas receptor‐dependent (type I) apoptotic pathway in obese Zucker rats. Research Methods and Procedures: Sixteen obese Zucker rats were studied...
Saved in:
Published in | Obesity (Silver Spring, Md.) Vol. 15; no. 10; pp. 2407 - 2415 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.10.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective: Very limited information regarding the cardiac molecular mechanism in obesity is available. The purpose of this study was to evaluate the cardiac Fas receptor‐dependent (type I) apoptotic pathway in obese Zucker rats.
Research Methods and Procedures: Sixteen obese Zucker rats were studied at 5 to 6 months of age, and 16 age‐matched lean Zucker rats served as controls. Heart weight index, myocardial architecture, key components of the Fas receptor‐dependent apoptotic pathway, apoptotic activity, and fibrosis in the excised left ventricle of rats were measured by weight scales, hematoxylin and eosin staining, Western blotting, TUNEL assay, and Masson trichrome staining.
Results: Body weight, whole heart weight, left ventricular weight, ratio of whole heart weight to tibia length, percentage of TUNEL‐positive cardiac myocytes, and percentage of cardiac fibrosis were significantly increased in the obese group. Cardiomyocyte disarray and increased cardiac interstitial space were observed in obese rats. Protein levels of Fas ligand, Fas death receptors, and Fas‐associated Death Domain were all significantly increased in the obese group. In addition, pro‐caspase‐8 and pro‐caspase‐3 were significantly decreased, whereas activated caspase‐8 and activated caspase‐3 were significantly increased in the obese group, which implies that pro‐forms of caspase‐8 and caspase‐3 were cleaved into active‐forms caspase‐8 and caspase‐3.
Conclusions: Cardiac Fas receptor‐dependent apoptotic pathways were more activated in obese rats’ hearts, which may provide one of the possible apoptotic mechanisms for developing cardiac abnormality in obesity. |
---|---|
AbstractList | Very limited information regarding the cardiac molecular mechanism in obesity is available. The purpose of this study was to evaluate the cardiac Fas receptor-dependent (type I) apoptotic pathway in obese Zucker rats.OBJECTIVEVery limited information regarding the cardiac molecular mechanism in obesity is available. The purpose of this study was to evaluate the cardiac Fas receptor-dependent (type I) apoptotic pathway in obese Zucker rats.Sixteen obese Zucker rats were studied at 5 to 6 months of age, and 16 age-matched lean Zucker rats served as controls. Heart weight index, myocardial architecture, key components of the Fas receptor-dependent apoptotic pathway, apoptotic activity, and fibrosis in the excised left ventricle of rats were measured by weight scales, hematoxylin and eosin staining, Western blotting, TUNEL assay, and Masson trichrome staining.RESEARCH METHODS AND PROCEDURESSixteen obese Zucker rats were studied at 5 to 6 months of age, and 16 age-matched lean Zucker rats served as controls. Heart weight index, myocardial architecture, key components of the Fas receptor-dependent apoptotic pathway, apoptotic activity, and fibrosis in the excised left ventricle of rats were measured by weight scales, hematoxylin and eosin staining, Western blotting, TUNEL assay, and Masson trichrome staining.Body weight, whole heart weight, left ventricular weight, ratio of whole heart weight to tibia length, percentage of TUNEL-positive cardiac myocytes, and percentage of cardiac fibrosis were significantly increased in the obese group. Cardiomyocyte disarray and increased cardiac interstitial space were observed in obese rats. Protein levels of Fas ligand, Fas death receptors, and Fas-associated Death Domain were all significantly increased in the obese group. In addition, pro-caspase-8 and pro-caspase-3 were significantly decreased, whereas activated caspase-8 and activated caspase-3 were significantly increased in the obese group, which implies that pro-forms of caspase-8 and caspase-3 were cleaved into active-forms caspase-8 and caspase-3.RESULTSBody weight, whole heart weight, left ventricular weight, ratio of whole heart weight to tibia length, percentage of TUNEL-positive cardiac myocytes, and percentage of cardiac fibrosis were significantly increased in the obese group. Cardiomyocyte disarray and increased cardiac interstitial space were observed in obese rats. Protein levels of Fas ligand, Fas death receptors, and Fas-associated Death Domain were all significantly increased in the obese group. In addition, pro-caspase-8 and pro-caspase-3 were significantly decreased, whereas activated caspase-8 and activated caspase-3 were significantly increased in the obese group, which implies that pro-forms of caspase-8 and caspase-3 were cleaved into active-forms caspase-8 and caspase-3.Cardiac Fas receptor-dependent apoptotic pathways were more activated in obese rats' hearts, which may provide one of the possible apoptotic mechanisms for developing cardiac abnormality in obesity.CONCLUSIONSCardiac Fas receptor-dependent apoptotic pathways were more activated in obese rats' hearts, which may provide one of the possible apoptotic mechanisms for developing cardiac abnormality in obesity. Very limited information regarding the cardiac molecular mechanism in obesity is available. The purpose of this study was to evaluate the cardiac Fas receptor-dependent (type I) apoptotic pathway in obese Zucker rats. Sixteen obese Zucker rats were studied at 5 to 6 months of age, and 16 age-matched lean Zucker rats served as controls. Heart weight index, myocardial architecture, key components of the Fas receptor-dependent apoptotic pathway, apoptotic activity, and fibrosis in the excised left ventricle of rats were measured by weight scales, hematoxylin and eosin staining, Western blotting, TUNEL assay, and Masson trichrome staining. Body weight, whole heart weight, left ventricular weight, ratio of whole heart weight to tibia length, percentage of TUNEL-positive cardiac myocytes, and percentage of cardiac fibrosis were significantly increased in the obese group. Cardiomyocyte disarray and increased cardiac interstitial space were observed in obese rats. Protein levels of Fas ligand, Fas death receptors, and Fas-associated Death Domain were all significantly increased in the obese group. In addition, pro-caspase-8 and pro-caspase-3 were significantly decreased, whereas activated caspase-8 and activated caspase-3 were significantly increased in the obese group, which implies that pro-forms of caspase-8 and caspase-3 were cleaved into active-forms caspase-8 and caspase-3. Cardiac Fas receptor-dependent apoptotic pathways were more activated in obese rats' hearts, which may provide one of the possible apoptotic mechanisms for developing cardiac abnormality in obesity. Objective: Very limited information regarding the cardiac molecular mechanism in obesity is available. The purpose of this study was to evaluate the cardiac Fas receptor‐dependent (type I) apoptotic pathway in obese Zucker rats. Research Methods and Procedures: Sixteen obese Zucker rats were studied at 5 to 6 months of age, and 16 age‐matched lean Zucker rats served as controls. Heart weight index, myocardial architecture, key components of the Fas receptor‐dependent apoptotic pathway, apoptotic activity, and fibrosis in the excised left ventricle of rats were measured by weight scales, hematoxylin and eosin staining, Western blotting, TUNEL assay, and Masson trichrome staining. Results: Body weight, whole heart weight, left ventricular weight, ratio of whole heart weight to tibia length, percentage of TUNEL‐positive cardiac myocytes, and percentage of cardiac fibrosis were significantly increased in the obese group. Cardiomyocyte disarray and increased cardiac interstitial space were observed in obese rats. Protein levels of Fas ligand, Fas death receptors, and Fas‐associated Death Domain were all significantly increased in the obese group. In addition, pro‐caspase‐8 and pro‐caspase‐3 were significantly decreased, whereas activated caspase‐8 and activated caspase‐3 were significantly increased in the obese group, which implies that pro‐forms of caspase‐8 and caspase‐3 were cleaved into active‐forms caspase‐8 and caspase‐3. Conclusions: Cardiac Fas receptor‐dependent apoptotic pathways were more activated in obese rats’ hearts, which may provide one of the possible apoptotic mechanisms for developing cardiac abnormality in obesity. Very limited information regarding the cardiac molecular mechanism in obesity is available. The purpose of this study was to evaluate the cardiac Fas receptor-dependent (type I) apoptotic pathway in obese Zucker rats. Sixteen obese Zucker rats were studied at 5 to 6 months of age, and 16 age-matched lean Zucker rats served as controls. Heart weight index, myocardial architecture, key components of the Fas receptor-dependent apoptotic pathway, apoptotic activity, and fibrosis in the excised left ventricle of rats were measured by weight scales, hematoxylin and eosin staining, Western blotting, TUNEL assay, and Masson trichrome staining. Body weight, whole heart weight, left ventricular weight, ratio of whole heart weight to tibia length, percentage of TUNEL-positive cardiac myocytes, and percentage of cardiac fibrosis were significantly increased in the obese group. Cardiomyocyte disarray and increased cardiac interstitial space were observed in obese rats. Protein levels of Fas ligand, Fas death receptors, and Fas-associated Death Domain were all significantly increased in the obese group. In addition, pro-caspase-8 and pro-caspase-3 were significantly decreased, whereas activated caspase-8 and activated caspase-3 were significantly increased in the obese group, which implies that pro-forms of caspase-8 and caspase-3 were cleaved into active-forms caspase-8 and caspase-3. Cardiac Fas receptor-dependent apoptotic pathways were more activated in obese rats' hearts, which may provide one of the possible apoptotic mechanisms for developing cardiac abnormality in obesity. Objective: Very limited information regarding the cardiac molecular mechanism in obesity is available. The purpose of this study was to evaluate the cardiac Fas receptor‐dependent (type I) apoptotic pathway in obese Zucker rats. Research Methods and Procedures: Sixteen obese Zucker rats were studied at 5 to 6 months of age, and 16 age‐matched lean Zucker rats served as controls. Heart weight index, myocardial architecture, key components of the Fas receptor‐dependent apoptotic pathway, apoptotic activity, and fibrosis in the excised left ventricle of rats were measured by weight scales, hematoxylin and eosin staining, Western blotting, TUNEL assay, and Masson trichrome staining. Results: Body weight, whole heart weight, left ventricular weight, ratio of whole heart weight to tibia length, percentage of TUNEL‐positive cardiac myocytes, and percentage of cardiac fibrosis were significantly increased in the obese group. Cardiomyocyte disarray and increased cardiac interstitial space were observed in obese rats. Protein levels of Fas ligand, Fas death receptors, and Fas‐associated Death Domain were all significantly increased in the obese group. In addition, pro‐caspase‐8 and pro‐caspase‐3 were significantly decreased, whereas activated caspase‐8 and activated caspase‐3 were significantly increased in the obese group, which implies that pro‐forms of caspase‐8 and caspase‐3 were cleaved into active‐forms caspase‐8 and caspase‐3. Conclusions: Cardiac Fas receptor‐dependent apoptotic pathways were more activated in obese rats’ hearts, which may provide one of the possible apoptotic mechanisms for developing cardiac abnormality in obesity. |
Author | Chen, Szu‐Hua Huang, Chih‐Yang Lu, Min‐Chi Yang, Ai‐Lan Tsai, Fuu‐Jen Kuo, Wei‐Wen Lee, Shin‐Da Lin, Yueh‐Min Wu, Fong‐Li Tzang, Bor‐Show |
Author_xml | – sequence: 1 givenname: Shin‐Da surname: Lee fullname: Lee, Shin‐Da – sequence: 2 givenname: Bor‐Show surname: Tzang fullname: Tzang, Bor‐Show – sequence: 3 givenname: Wei‐Wen surname: Kuo fullname: Kuo, Wei‐Wen – sequence: 4 givenname: Yueh‐Min surname: Lin fullname: Lin, Yueh‐Min – sequence: 5 givenname: Ai‐Lan surname: Yang fullname: Yang, Ai‐Lan – sequence: 6 givenname: Szu‐Hua surname: Chen fullname: Chen, Szu‐Hua – sequence: 7 givenname: Fuu‐Jen surname: Tsai fullname: Tsai, Fuu‐Jen – sequence: 8 givenname: Fong‐Li surname: Wu fullname: Wu, Fong‐Li – sequence: 9 givenname: Min‐Chi surname: Lu fullname: Lu, Min‐Chi – sequence: 10 givenname: Chih‐Yang surname: Huang fullname: Huang, Chih‐Yang |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17925466$$D View this record in MEDLINE/PubMed |
BookMark | eNp90U1rFTEUBuAgFfuhO9cyILjy3uZjksws68V-QOGWoqBuwknmDKbOnUyTDOXu_An-Rn-JKbd2UcRVQnjOSzjvIdkbw4iEvGZ0yahojoPdLjmleskb9YwcsFbQhRbtl73He8P2yWFKN5TWikr2guwz3XJZK3VAzlYQOw-uOoVUXaPDKYf4--evDiccOxxzdTKF8pa9q64gf7-DbeXHam0xYfVtdj8wVteQ00vyvIch4auH84h8Pv34aXW-uFyfXaxOLhdOtIotLFOKclqjBdaBQs4kt42T0ICuuUV0jGFve-xbAZJzEF3PRGMl10h114sj8m6XO8VwO2PKZuOTw2GAEcOcjGqE1q1sC3z7BN6EOY7lb6asjda1FK0u6s2Dmu0GOzNFv4G4NX8XVADfARdDShF743yG7MOYI_ihZN3HNaa0YO5bMKWFMvT-ydBj7r853fE7P-D2v9asP3wVkok_NqeYBA |
CitedBy_id | crossref_primary_10_1002_cbf_1687 crossref_primary_10_1016_j_numecd_2011_06_008 crossref_primary_10_1016_j_lfs_2013_01_027 crossref_primary_10_1093_ecam_nep182 crossref_primary_10_1155_2020_4745389 crossref_primary_10_1371_journal_pone_0065172 crossref_primary_10_1002_jcb_26440 crossref_primary_10_1371_journal_pone_0208633 crossref_primary_10_1016_j_jep_2016_07_018 crossref_primary_10_1007_s11906_008_0085_z crossref_primary_10_3390_ijms231810266 crossref_primary_10_1161_CIRCULATIONAHA_112_091215 crossref_primary_10_1016_j_lfs_2015_02_016 crossref_primary_10_1007_s11655_016_2602_2 crossref_primary_10_1016_j_maturitas_2008_07_004 crossref_primary_10_1186_s12906_015_0698_0 crossref_primary_10_1016_j_numecd_2011_11_002 crossref_primary_10_3390_ijms17122036 crossref_primary_10_1016_j_ijcard_2014_04_132 crossref_primary_10_1016_j_steroids_2022_108980 crossref_primary_10_1002_cbf_2982 crossref_primary_10_1016_j_orcp_2023_11_006 crossref_primary_10_7570_jomes20120 crossref_primary_10_1007_s12012_016_9370_2 crossref_primary_10_3892_ijmm_2013_1524 crossref_primary_10_3892_ijmm_2014_2021 crossref_primary_10_1016_j_lfs_2013_04_002 crossref_primary_10_1016_j_bbadis_2016_01_011 crossref_primary_10_1111_jfbc_13062 crossref_primary_10_1113_jphysiol_2008_166033 crossref_primary_10_1152_japplphysiol_00152_2007 crossref_primary_10_1371_journal_pone_0015167 crossref_primary_10_1002_tox_22906 crossref_primary_10_1016_j_bbadis_2014_04_032 crossref_primary_10_1016_j_jnutbio_2019_03_007 crossref_primary_10_1016_j_biomed_2011_12_004 |
Cites_doi | 10.1097/00000441-200104000-00003 10.1152/jappl.2001.90.5.1707 10.1056/NEJMoa020245 10.1161/01.HYP.28.6.1047 10.1016/j.ijcard.2005.05.046 10.1161/01.RES.0000199348.10580.1d 10.1056/NEJMe020065 10.1016/j.ijcard.2003.07.001 10.1161/01.RES.82.11.1111 10.1016/S1471-4892(01)00032-7 10.1016/S1054-8807(03)00109-1 10.1016/j.ijcard.2006.03.064 10.1073/pnas.97.4.1784 10.1016/S0031-6997(24)01434-0 10.1016/S1050-1738(01)00160-8 10.1161/01.CIR.0000124229.40424.80 10.1038/sj.ijo.0801663 10.1038/oby.2001.53 10.1301/nr.2004.mar.120-124 10.1164/ajrccm.150.2.8049815 10.1152/ajpendo.00127.2005 10.1097/00005082-200311000-00007 10.1111/j.1527-5299.2002.00717.x 10.1038/415240a 10.1073/pnas.96.14.8144 10.1164/ajrccm.163.5.2004230 10.1164/ajrccm.162.3.9909058 10.1038/oby.2005.58 10.1096/fj.00-0590 |
ContentType | Journal Article |
Copyright | 2007 North American Association for the Study of Obesity (NAASO) Copyright Nature Publishing Group Oct 2007 |
Copyright_xml | – notice: 2007 North American Association for the Study of Obesity (NAASO) – notice: Copyright Nature Publishing Group Oct 2007 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
DOI | 10.1038/oby.2007.286 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Physical Therapy |
EISSN | 1930-739X |
EndPage | 2415 |
ExternalDocumentID | 2725996211 17925466 10_1038_oby_2007_286 OBY351 |
Genre | miscellaneous Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | China Taiwan |
GeographicLocations_xml | – name: China – name: Taiwan |
GroupedDBID | --- 05W 0R~ 123 1OC 29N 2FS 2WC 31~ 33P 39C 3SF 4.4 50Y 52U 52V 53G 70F 8-1 AAESR AAEVG AAFWJ AAHBH AAHQN AAIPD AAMMB AAMNL AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCUV ABIVO ABJNI ABLJU ABQWH ABXGK ACAHQ ACCZN ACGFS ACGOF ACMXC ACPOU ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFPM AFGKR AFWVQ AFZJQ AGHNM AGXDD AGYGG AHBTC AHMBA AIACR AIDQK AIDYY AITYG AIURR ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZVAB BAWUL BFHJK BHBCM BKNYI BMXJE BOGZA BPHCQ BRXPI BVXVI CS3 DCZOG DIK DPXWK DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN F5P FUBAC G-S GODZA HGLYW HZ~ KBYEO LATKE LEEKS LH4 LITHE LOXES LUTES LW6 LYRES MEWTI MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ O66 O9- OK1 P2W PQQKQ PROAC R.K ROL SUPJJ WBKPD WHG WHWMO WIH WIJ WIK WIN WOHZO WOQ WQJ WVDHM WXSBR YHZ AAHHS AAYXX ACCFJ AEEZP AEQDE AIWBW AJBDE ALIPV CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
ID | FETCH-LOGICAL-c3961-b1660204eba1da6e2152b8c5a8a742beec11efbfef93a522a3df138b527e07df3 |
ISSN | 1930-7381 |
IngestDate | Fri Jul 11 15:21:27 EDT 2025 Fri Jul 25 23:54:20 EDT 2025 Thu Apr 03 07:11:59 EDT 2025 Thu Apr 24 23:03:32 EDT 2025 Tue Jul 01 01:15:59 EDT 2025 Wed Aug 20 07:24:48 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3961-b1660204eba1da6e2152b8c5a8a742beec11efbfef93a522a3df138b527e07df3 |
Notes | Drs. Lu and Huang contributed equally to this study. The costs of publication of this article were defrayed, in part, by the payment of page charges. This article must, therefore, be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/oby.2007.286 |
PMID | 17925466 |
PQID | 1030445397 |
PQPubID | 105348 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_68377959 proquest_journals_1030445397 pubmed_primary_17925466 crossref_citationtrail_10_1038_oby_2007_286 crossref_primary_10_1038_oby_2007_286 wiley_primary_10_1038_oby_2007_286_OBY351 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | October 2007 |
PublicationDateYYYYMMDD | 2007-10-01 |
PublicationDate_xml | – month: 10 year: 2007 text: October 2007 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: United States – name: Silver Spring |
PublicationTitle | Obesity (Silver Spring, Md.) |
PublicationTitleAlternate | Obesity (Silver Spring) |
PublicationYear | 2007 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 2001; 321 2004; 62 2001; 163 2001; 90 2006; 98 2002; 12 1994; 150 2002; 8 2003; 35 2002; 415 1996 2006; 291 2003; 18 1998; 82 2004; 109 2001; 25 1993; 2 2004; 94 1996; 28 2006; 108 2007; 116 2001; 9 2000; 52 2004; 13 2000; 97 2000; 162 2002; 347 2001; 15 1999; 96 2001; 1 2005; 13 e_1_2_7_5_2 e_1_2_7_4_2 e_1_2_7_3_2 e_1_2_7_2_2 e_1_2_7_9_2 e_1_2_7_8_2 e_1_2_7_7_2 e_1_2_7_6_2 e_1_2_7_19_2 e_1_2_7_18_2 e_1_2_7_17_2 e_1_2_7_16_2 e_1_2_7_15_2 e_1_2_7_14_2 e_1_2_7_12_2 e_1_2_7_11_2 e_1_2_7_10_2 e_1_2_7_26_2 e_1_2_7_27_2 National Institutes of Health (e_1_2_7_24_2) 1996 e_1_2_7_28_2 e_1_2_7_29_2 Clark K. (e_1_2_7_13_2) 2003; 35 Alexander JK. (e_1_2_7_25_2) 1993; 2 Kim S. (e_1_2_7_23_2) 2000; 52 e_1_2_7_30_2 e_1_2_7_31_2 e_1_2_7_22_2 e_1_2_7_32_2 e_1_2_7_21_2 e_1_2_7_33_2 e_1_2_7_20_2 |
References_xml | – volume: 109 start-page: 1877 year: 2004 end-page: 1885 article-title: Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron‐overload murine model publication-title: Circulation – volume: 96 start-page: 8144 year: 1999 end-page: 8149 article-title: Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase‐3 in human cardiomyopathy publication-title: Proc Natl Acad Sci USA – volume: 2 start-page: 317 year: 1993 end-page: 321 article-title: Obesity and the heart publication-title: Heart Dis Stroke – volume: 82 start-page: 1111 year: 1998 end-page: 1129 article-title: Apoptosis: basic mechanisms and implications for cardiovascular disease publication-title: Circ Res – volume: 116 start-page: 348 year: 2007 end-page: 356 article-title: Effects of long‐term intermittent hypoxia on mitochondrial and Fas death receptor dependent apoptotic pathways in rat hearts publication-title: Int J Cardiol – volume: 15 start-page: 312 year: 2001 end-page: 321 article-title: Diseases of liporegulation: new perspective on obesity and related disorders publication-title: FASEB J – volume: 90 start-page: 1707 year: 2001 end-page: 1713 article-title: GABAergic modulation of ventilation and peak oxygen consumption in obese Zucker rats publication-title: J Appl Physiol – volume: 162 start-page: 1009 year: 2000 end-page: 1015 article-title: Endogenous opioids modulate ventilation and peak oxygen consumption in obese Zucker rats publication-title: Am J Respir Crit Care Med – year: 1996 – volume: 28 start-page: 1047 year: 1996 end-page: 1054 article-title: Hypertension in obese Zucker rats: role of angiotensin II and adrenergic activity publication-title: Hypertension – volume: 9 start-page: 407 year: 2001 end-page: 413 article-title: Opioidergic modulation of ventilatory response to sustained hypoxia in obese Zucker rats publication-title: Obes Res – volume: 13 start-page: 11 year: 2004 end-page: 19 article-title: Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats publication-title: Cardiovasc Pathol – volume: 98 start-page: 119 year: 2006 end-page: 124 article-title: Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity publication-title: Circ Res – volume: 415 start-page: 240 year: 2002 end-page: 243 article-title: Myocyte renewal and ventricular remodelling publication-title: Nature – volume: 35 start-page: 59 year: 2003 end-page: 60 article-title: Obesity and the risk of heart failure publication-title: J Insur Med – volume: 1 start-page: 141 year: 2001 end-page: 150 article-title: Molecular mechanisms of apoptosis in the cardiac myocyte publication-title: Curr Opin Pharmacol – volume: 291 start-page: E306 year: 2006 end-page: E314 article-title: Roles of insulin‐likegrowth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation publication-title: Am J Physiol Endocrinol Metab – volume: 163 start-page: 1191 year: 2001 end-page: 1197 article-title: Serotonergic modulation of ventilation and upper airway stability in obese Zucker rats publication-title: Am J Respir Crit Care Med – volume: 347 start-page: 358 year: 2002 end-page: 359 article-title: Obesity and heart failure: risk factor or mechanism? publication-title: N Engl J Med – volume: 347 start-page: 305 year: 2002 end-page: 313 article-title: Obesity and the risk of heart failure publication-title: N Engl J Med – volume: 150 start-page: 356 year: 1994 end-page: 362 article-title: Pulmonary ventilation and mechanics in morbidly obese Zucker rats publication-title: Am J Respir Crit Care Med – volume: 25 start-page: 997 year: 2001 end-page: 1004 article-title: NMDA receptor‐mediated modulation of ventilation in obese Zucker rats publication-title: Int J Obes Relat Metab Disord – volume: 108 start-page: 376 year: 2006 end-page: 384 article-title: Effects of short‐ and long‐term hypobaric hypoxia on Bcl2 family in rat heart publication-title: Int J Cardiol – volume: 18 start-page: 360 year: 2003 end-page: 366 article-title: Obesity and heart failure publication-title: J Cardiovasc Nurs – volume: 62 start-page: 120 year: 2004 end-page: 124 article-title: Iron, oxidative stress, and disease risk publication-title: Nutr Rev – volume: 12 start-page: 97 year: 2002 end-page: 101 article-title: Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction publication-title: Trends Cardiovasc Med – volume: 52 start-page: 11 year: 2000 end-page: 34 article-title: Molecular and cellular mechanisms of angiotensin II‐mediated cardiovascular and renal diseases publication-title: Pharmacol Rev – volume: 13 start-page: 545 year: 2005 end-page: 555 article-title: Adenosinergic modulation of ventilation in obese Zucker rats publication-title: Obes Res – volume: 8 start-page: 132 year: 2002 end-page: 140 article-title: Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure publication-title: Congest Heart Fail – volume: 97 start-page: 1784 year: 2000 end-page: 1789 article-title: Lipotoxic heart disease in obese rats: implications for human obesity publication-title: Proc Natl Acad Sci USA – volume: 94 start-page: 105 year: 2004 end-page: 110 article-title: Increased apoptosis in remote non‐infarcted myocardium in multivessel coronary disease publication-title: Int J Cardiol – volume: 321 start-page: 225 year: 2001 end-page: 236 article-title: Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome publication-title: Am J Med Sci – ident: e_1_2_7_11_2 doi: 10.1097/00000441-200104000-00003 – volume: 2 start-page: 317 year: 1993 ident: e_1_2_7_25_2 article-title: Obesity and the heart publication-title: Heart Dis Stroke – ident: e_1_2_7_9_2 doi: 10.1152/jappl.2001.90.5.1707 – ident: e_1_2_7_33_2 doi: 10.1056/NEJMoa020245 – ident: e_1_2_7_7_2 doi: 10.1161/01.HYP.28.6.1047 – ident: e_1_2_7_27_2 doi: 10.1016/j.ijcard.2005.05.046 – ident: e_1_2_7_32_2 doi: 10.1161/01.RES.0000199348.10580.1d – ident: e_1_2_7_12_2 doi: 10.1056/NEJMe020065 – ident: e_1_2_7_16_2 doi: 10.1016/j.ijcard.2003.07.001 – volume-title: Guide for the Care and Use of Laboratory Animals year: 1996 ident: e_1_2_7_24_2 – ident: e_1_2_7_15_2 doi: 10.1161/01.RES.82.11.1111 – ident: e_1_2_7_18_2 doi: 10.1016/S1471-4892(01)00032-7 – ident: e_1_2_7_8_2 doi: 10.1016/S1054-8807(03)00109-1 – ident: e_1_2_7_19_2 doi: 10.1016/j.ijcard.2006.03.064 – ident: e_1_2_7_30_2 doi: 10.1073/pnas.97.4.1784 – volume: 52 start-page: 11 year: 2000 ident: e_1_2_7_23_2 article-title: Molecular and cellular mechanisms of angiotensin II‐mediated cardiovascular and renal diseases publication-title: Pharmacol Rev doi: 10.1016/S0031-6997(24)01434-0 – ident: e_1_2_7_28_2 doi: 10.1016/S1050-1738(01)00160-8 – ident: e_1_2_7_21_2 doi: 10.1161/01.CIR.0000124229.40424.80 – ident: e_1_2_7_3_2 doi: 10.1038/sj.ijo.0801663 – ident: e_1_2_7_2_2 doi: 10.1038/oby.2001.53 – ident: e_1_2_7_20_2 doi: 10.1301/nr.2004.mar.120-124 – ident: e_1_2_7_5_2 doi: 10.1164/ajrccm.150.2.8049815 – ident: e_1_2_7_26_2 doi: 10.1152/ajpendo.00127.2005 – ident: e_1_2_7_14_2 doi: 10.1097/00005082-200311000-00007 – volume: 35 start-page: 59 year: 2003 ident: e_1_2_7_13_2 article-title: Obesity and the risk of heart failure publication-title: J Insur Med – ident: e_1_2_7_22_2 doi: 10.1111/j.1527-5299.2002.00717.x – ident: e_1_2_7_29_2 doi: 10.1038/415240a – ident: e_1_2_7_17_2 doi: 10.1073/pnas.96.14.8144 – ident: e_1_2_7_6_2 doi: 10.1164/ajrccm.163.5.2004230 – ident: e_1_2_7_10_2 doi: 10.1164/ajrccm.162.3.9909058 – ident: e_1_2_7_4_2 doi: 10.1038/oby.2005.58 – ident: e_1_2_7_31_2 doi: 10.1096/fj.00-0590 |
SSID | ssj0046051 |
Score | 2.070173 |
Snippet | Objective: Very limited information regarding the cardiac molecular mechanism in obesity is available. The purpose of this study was to evaluate the cardiac... Objective: Very limited information regarding the cardiac molecular mechanism in obesity is available. The purpose of this study was to evaluate the cardiac... Very limited information regarding the cardiac molecular mechanism in obesity is available. The purpose of this study was to evaluate the cardiac Fas... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2407 |
SubjectTerms | Adapter proteins animal models Animals Apoptosis Biotechnology Body Weight Cardiomyocytes Cardiomyopathies - etiology Cardiomyopathies - metabolism Cardiomyopathies - pathology Cardiomyopathy Caspase 3 - analysis Caspase 3 - metabolism Caspase 8 - analysis Caspase 8 - metabolism fas Receptor - agonists fas Receptor - metabolism Fibrosis Heart failure Hospitals Hypertension Ligands Male Myocardium - metabolism Myocardium - pathology Obesity Obesity - complications Obesity - metabolism Organ Size Physical therapy Rats Rats, Zucker Receptors, Death Domain - agonists Receptors, Death Domain - metabolism Research methodology Science Zucker rats |
Title | Cardiac Fas Receptor‐dependent Apoptotic Pathway in Obese Zucker Rats |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1038%2Foby.2007.286 https://www.ncbi.nlm.nih.gov/pubmed/17925466 https://www.proquest.com/docview/1030445397 https://www.proquest.com/docview/68377959 |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELaWIiEuiH8WCvgAB7TKksRxfo60UAplAbFbteUS2YmjXQkliG6E6IlH4A14N56EGdvxprCgwiVa2Z44m_liz4znh5AHkgHTy5h5JQsLL6pi5cki4p7kWYmYEZlE08Dkdby7H7085IeDwfee11K7lOPiZG1cyf9wFdqArxgl-w-cdTeFBvgN_IUrcBiuZ-LxtmZvMdoRGO2BDiqgfHfeC1152yVImg30YGbWtyDvfRY61A8rAqjRe-1WMXonTEKnTky15QJQ_Jwu0Hd6ZAyA2nxajnvmA-vIM50vajfzU7fUz06sOXqr92DTeeMM53utNtUeqIXrPlgFp70yCQ6OWjV33RObKryzVCTO561bXDPmewkzJVrGqt-my-muVmTeR57fX18jUyPX7tUofqzdB0zW90Z-MUkqw3Xptn_ZBp1zoj6WZ2kO1FikM8mB-hw5H4IeonX2F3vdVo9nyoFxWzB_zEZWAPXj_tynZZ7fFJnTepEWbGaXySWrkdAnBl5XyEDVV8mFifW5uEaeW5RRQBntUPbj6zeHL-rwRS2-6KKmGl_U4Isivq6T_Z1ns-1dz5bf8AqWxYEngzjG0GklRVCKWGEFZJkWXKQiiUKpVBEEqpKVqjImQIwXrKwClkoeJspPyordIBt1U6tbhHLFsyIEVZ8BqRIp6CShEGEGBInPZTQko-4F5YXNTY8lUj7k65gxJA_d6I8mJ8sfxm127zq3X-0xjvKjiIMYPiT3XTesqXhQJmrVtMd5nGIaTp4NyU3DodU0SYYFJODWjzTL_jp__mbriPHg9hkf9w65uPpqNsnG8lOr7oLEu5T3NOp-AlPnoNo |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cardiac+Fas+Receptor%E2%80%90dependent+Apoptotic+Pathway+in+Obese+Zucker+Rats&rft.jtitle=Obesity+%28Silver+Spring%2C+Md.%29&rft.au=Lee%2C+Shin%E2%80%90Da&rft.au=Tzang%2C+Bor%E2%80%90Show&rft.au=Kuo%2C+Wei%E2%80%90Wen&rft.au=Lin%2C+Yueh%E2%80%90Min&rft.date=2007-10-01&rft.issn=1930-7381&rft.eissn=1930-739X&rft.volume=15&rft.issue=10&rft.spage=2407&rft.epage=2415&rft_id=info:doi/10.1038%2Foby.2007.286&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_oby_2007_286 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1930-7381&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1930-7381&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1930-7381&client=summon |